COFEPRIS Celebrates 20th Anniversary
News Article
To celebrate its first two decades, COFEPRIS held an event to continue promoting innovation and health protection.
Information sign
News Article
After COFEPRIS denied a transparency request for the approval document of the Sinovac vaccine, INAI urged the council to deliver the document.
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
News Article
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
Midterm Elections’ Impact on Healthcare
Analysis
After many controversial reform proposals during AMLO’s administration, the sector sees a calmer future.
Hand holding a vaccine flask
News Article
COFEPRIS has greenlit the single-dose vaccine. This may entail better vaccination rates and relief efforts
Nitrosamine, the Industry’s Silent Growing Concern
News Article
COVID-19 is not the only concern for the health industry. Learn about the potential threat nitrosamine poses to the pharma market.
Deyanira Chiñas
Expert Contributor
Deyanira Chiñas
Commercial Director
T5DC
https://www.linkedin.com/in/deyanira-chi%C3%B1as-0624b317/
https://www.t5dc.com.mx
0
Hospital pharmacies are receiving high-risk drugs in Dutch, Russian and Arabic, which no one can read. The risk to patients is massive.
Mexico Calls Out Vaccine Monopoly
Weekly Roundups
Fair distribution and cooperation are essential to get over crisis. Are all countries contributing to the same cause?
Melissa Rosales
Expert Contributor
Melissa Rosales
Director General
RM Pharma
https://www.linkedin.com/in/melissa-rosales-cort%C3%A9s-5a738389/
https://twitter.com/rmpharmas
https://www.rmpharma.mx/nosotros
Ethics is important in clinical research, and guidelines have been developed to provide clarity because many people are involved in a clinical trial.
Subscribe to COFEPRIS